Form 4: Concentrix Executive Sells 500 Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Cormac J. Twomey, EVP of Global Ops & Delivery at Concentrix Corp, sold 500 shares of common stock at $45.15 per share under a pre-arranged 10b5-1 trading plan.
Summary
- Cormac J. Twomey, an Executive Vice President at Concentrix Corp, sold 500 shares of the company's common stock.
- The sale occurred on November 29, 2024, at a price of $45.15 per share.
- This transaction was executed under a pre-existing Rule 10b5-1 trading plan adopted on January 29, 2024.
- Following the sale, Twomey directly owns 24,436 shares of Concentrix stock.
Sentiment
Score: 5
Explanation: The document is a routine Form 4 filing for an executive stock sale under a pre-arranged plan, which is neither positive nor negative.
Risks
- Executive stock sales can sometimes be perceived negatively by the market, although this sale was pre-planned.
Industry Context
Executive stock sales are a common occurrence and are often part of pre-planned strategies, such as 10b5-1 trading plans, to avoid accusations of insider trading. This transaction is not unusual for a company of this size.
Comparison to Industry Standards
- Executive stock sales are a common practice across publicly traded companies, and the use of 10b5-1 plans is a standard method for executives to manage their personal finances while avoiding insider trading concerns.
- Comparable companies such as Teleperformance and TaskUs also see regular Form 4 filings from their executives, indicating similar practices.
- The volume of shares sold is relatively small compared to the total outstanding shares of Concentrix, suggesting it is unlikely to have a significant impact on the stock price.
Stakeholder Impact
- The impact on shareholders is likely to be minimal, as the sale was pre-planned and the volume of shares is small.
Key Dates
| Date | Description |
|---|---|
| 01/29/2024 | Date the Rule 10b5-1 trading plan was adopted by the reporting person. |
| 11/29/2024 | Date of the stock sale transaction. |
| 12/03/2024 | Date the Form 4 was signed. |
Keywords
Concentrix, stock sale, insider trading, Form 4, 10b5-1 plan, executive, CNXC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.